Literature DB >> 9348210

The different forms of the prolactin receptor in the rat corpus luteum: developmental expression and hormonal regulation in pregnancy.

C M Telleria1, T G Parmer, L Zhong, D L Clarke, C T Albarracin, W R Duan, D I Linzer, G Gibori.   

Abstract

The corpora lutea of pregnancy in the rat are highly dependent on the action of PRL and PRL-like hormones to hypertrophy and to produce progesterone needed for the maintenance of gestation. Two forms of the PRL receptor (PRL-R), designated as long (PRL-RL) and short (PRL-RS), have been described in rat tissues. To determine whether both forms are present in the corpus luteum during pregnancy and to examine the developmental and hormonal regulation of their expression, total RNA isolated from corpora lutea at different stages of pregnancy and from highly luteinized granulosa cells subjected to different hormonal treatments were analyzed by semiquantitative RT-PCR. Immunoblotting of luteal proteins from early and late pregnancy was also performed to determine if the pattern of PRL-R proteins follows that of PRL-R messenger RNA (mRNA) expression. In addition, the correlation between the well characterized PRL-regulated gene, 20alpha-hydroxysteroid dehydrogenase (20alpha-HSD), and PRL-R gene expression was investigated during the time of luteolysis. Both PRL-RL and PRL-RS mRNA and protein were expressed in corpora lutea of pregnancy, with the long form being the most dominant at all stages. Whereas no changes in mRNA level of either PRL-RL or PRL-RS were found until day 20 of gestation, a profound decline in PRL-R mRNA and protein for both receptor types occurred at the end of pregnancy. This drop in PRL-R expression was accompanied by a sharp and abrupt expression of 20alpha-HSD mRNA. Studies performed in vivo and in luteinized cells in culture indicate that PRL can up-regulate the expression of the PRL-RL mRNA, an effect prevented by the tyrosine kinase inhibitor, genistein. PRL-RL mRNA was also selectively increased by cAMP. In summary, the results of this investigation have established that: 1) the corpus luteum of pregnancy expresses both the short and long forms of the PRL-R with the long form being more abundant; 2) the mRNA for both forms of the PRL-R remains at constant levels throughout pregnancy but drops before parturition; 3) the decline in PRL-R mRNA at the end of pregnancy is accompanied by a dramatic rise in 20alpha-HSD; 4) PRL is able to increase the expression of PRL-R mRNA; and that 5) both A kinase and tyrosine kinase mediated pathways appear to participate in the up-regulatory mechanism involved in PRL-R mRNA expression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9348210     DOI: 10.1210/endo.138.11.5479

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  14 in total

1.  Systematic determination of differential gene expression in the primate corpus luteum during the luteal phase of the menstrual cycle.

Authors:  Randy L Bogan; Melinda J Murphy; Richard L Stouffer; Jon D Hennebold
Journal:  Mol Endocrinol       Date:  2008-02-07

2.  Regulation of transcription factors and repression of Sp1 by prolactin signaling through the short isoform of its cognate receptor.

Authors:  Y Sangeeta Devi; Aurora Shehu; Carlos Stocco; Julia Halperin; Jamie Le; Anita M Seibold; Michal Lahav; Nadine Binart; Geula Gibori
Journal:  Endocrinology       Date:  2009-04-02       Impact factor: 4.736

3.  Prolactin prevents hepatocellular carcinoma by restricting innate immune activation of c-Myc in mice.

Authors:  Hadley J Hartwell; Keiko Y Petrosky; James G Fox; Nelson D Horseman; Arlin B Rogers
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-21       Impact factor: 11.205

4.  Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase.

Authors:  Y Sangeeta Devi; Anita M Seibold; Aurora Shehu; Evelyn Maizels; Julia Halperin; Jamie Le; Nadine Binart; Lei Bao; Geula Gibori
Journal:  J Biol Chem       Date:  2011-01-03       Impact factor: 5.157

5.  Generation of mice expressing only the long form of the prolactin receptor reveals that both isoforms of the receptor are required for normal ovarian function.

Authors:  Jamie A Le; Heather M Wilson; Aurora Shehu; Jifang Mao; Y Sangeeta Devi; Julia Halperin; Tetley Aguilar; Anita Seibold; Evelyn Maizels; Geula Gibori
Journal:  Biol Reprod       Date:  2012-03-22       Impact factor: 4.285

6.  Prolactin signaling through the short form of its receptor represses forkhead transcription factor FOXO3 and its target gene galt causing a severe ovarian defect.

Authors:  Julia Halperin; Y Sangeeta Devi; Sangeeta Y Devi; Shai Elizur; Carlos Stocco; Aurora Shehu; Diane Rebourcet; Terry G Unterman; Nancy D Leslie; Jamie Le; Nadine Binart; Geula Gibori
Journal:  Mol Endocrinol       Date:  2007-11-01

Review 7.  What can we learn from rodents about prolactin in humans?

Authors:  Nira Ben-Jonathan; Christopher R LaPensee; Elizabeth W LaPensee
Journal:  Endocr Rev       Date:  2007-12-05       Impact factor: 19.871

8.  Exogenous estradiol enhances apoptosis in regressing post-partum rat corpora lutea possibly mediated by prolactin.

Authors:  Alicia A Goyeneche; Carlos M Telleria
Journal:  Reprod Biol Endocrinol       Date:  2005-08-30       Impact factor: 5.211

9.  Prolactin signaling through the short isoform of the mouse prolactin receptor regulates DNA binding of specific transcription factors, often with opposite effects in different reproductive issues.

Authors:  Y Sangeeta Devi; Aurora Shehu; Julia Halperin; Carlos Stocco; Jamie Le; Anita M Seibold; Geula Gibori
Journal:  Reprod Biol Endocrinol       Date:  2009-08-24       Impact factor: 5.211

10.  Prolactin promotes a partial recovery from the atrophy of both male and female gerbil prostates caused by castration.

Authors:  Marianna Zanatelli; Simone Jacovaci Colleta; Luiz Henrique Alves Guerra; Fernanda Cristina Alcântara Santos; Rejane Maira Góes; Patricia Simone Leite Vilamaior; Sebastião Roberto Taboga
Journal:  Reprod Biol Endocrinol       Date:  2021-06-22       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.